Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 91
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01100879 | Ferric Carboxymaltose for Treatment of Anaemia of Cancer in Subjects With Multiple Myeloma Receiving Chemotherapy | ||
| NCT04364269 | Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Preliminary Efficacy of VIT-2763 in β-thalassaemia | ||
| NCT05077436 | Bioavailability Study Comparing 2 Vamifeport Oral Formulations in Fasted Versus Fed State in Healthy Subjects | ||
| NCT01101399 | Ferric Carboxymaltose in Subjects With Functional Iron Deficiency Undergoing Chemotherapy | ||
| NCT03047954 | Broncho-Vaxom (OM 85 BV) in Children Suffering From Atopic Dermatitis | ||
| NCT03010072 | The Effect of Phosphate Lowering Using Sucroferric Oxyhydroxide (PA21) on Calcification Propensity of Serum | ||
| NCT05766839 | Patiromer for Treatment of Hyperkalaemia in Children Under 12 Years of Age | ||
| NCT01820949 | Safety and Effectiveness of a Patient Blood Management (PBM) Program in Surgical Patients | ||
| NCT05460234 | RAYALDEE Non Interventional Study (NIS) on Effectiveness in ND-CKD SHPT Patients | ||
| NCT05625542 | Cross-sectional Study to Assess Prevalence and Burden of CKD-associated Pruritus in Hemodialysis Patients | ||
| NCT02033317 | An Open-Label, Multiple Dose Study to Evaluate the Pharmacology, Safety, and Tolerability of Patiromer in Participants on Hemodialysis | ||
| NCT04510792 | IMpact of hyPeRkalaemia on thErapy With Renin angiotenSin aldoSterone System Inhibitors | ||
| NCT01477424 | A Drug-Drug Interaction Study of Warfarin and PA21 | ||
| NCT00520780 | Ferinject® Assessment in Patients With Iron Deficiency and Chronic Heart Failure (FAIR-HF) | ||
| NCT05389826 | mHealth for Phosphorus Management in CKD. | ||
| NCT01464190 | A Phase 3 Extension Study to Investigate the Long-term Safety, Tolerability and Efficacy of PA21, a Phosphate Binder in Dialysis Patients | ||
| NCT01453608 | A Study to Compare the Use of Ferric Carboxymaltose With Placebo in Patients With Chronic Heart Failure and Iron Deficiency | ||
| NCT02687594 | Non-interventional Study to Investigate the Short and Long Term Real-life Safety, Effectiveness, and Adherence of Velphoro® in Patients With Hyperphosphataemia Undergoing Haemodialysis (HD) or Peritoneal Dialysis (PD) | ||
| NCT05786469 | Patiromer Trial in CKD Stage IIIB to V | ||
| NCT02557477 | Omega 3/6 Fatty Acids for Reading in Children | ||
| NCT05751772 | Improving Knowledge in Heart Failure Inpatient With Therapeutic Education | ||
| NCT03644264 | PA21 Safety and Efficacy in Adult Chinese Subjects | ||
| NCT02213653 | Randomized Study Evaluating Agents Stimulants Erythropoiesis (ASE) Associated With Ferric Carboxymaltose (Ferinject ®) in Concomitant or Sequential Patients Treated for Cancer and With Anemia Associated With Functional Iron Deficiency | ||
| NCT03087058 | Pharmacodynamic & Safety of Patiromer in Children & Adolescents (2-<18 Yrs) With Chronic Kidney Disease and Hyperkalemia | ||
| NCT05897684 | Avacostar - (PASS) | ||
| NCT01345968 | Intravenous Ferric Carboxymaltose (Ferinject) in Patients Undergoing Orthopaedic Surgery | ||
| NCT04864795 | Cardiovascular and Renal Treatment in Heart Failure Patients With Hyperkalaemia or at High Risk of Hyperkalaemia | ||
| NCT04817670 | Study to Assess Efficacy and Safety of VIT-2763 (Vamifeport) in Subjects With Sickle Cell Disease | ||
| NCT02694744 | Patiromer With or Without Food for the Treatment of Hyperkalemia | ||
| NCT00746551 | Intravenous Versus Oral Iron in Late Pregnancy: Results of Treatment | ||
| NCT01371747 | Patiromer in the Treatment of Hyperkalemia in Patients With Hypertension and Diabetic Nephropathy (AMETHYST-DN) | ||
| NCT04249648 | Hyperkalaemia and Its Impact on Therapy with RAASi | ||
| NCT01130597 | Evaluation of Patiromer Titration in Heart Failure Patients With Chronic Kidney Disease | ||
| NCT06434025 | IV Iron and SGLT2 Inhibitor on Ventricular Function and Myocardial Iron Content in Heart Failure With Iron Deficiency | ||
| NCT05885737 | Phase 3 Study of Difelikefalin in Haemodialysis Chinese Adult Subjects With Moderate-to-Severe Pruritus | ||
| NCT02243735 | Trial Comparing Ferric(III)Carboxymaltose Infusion With Oral Iron Suppletion as Treatment of Anaemia | ||
| NCT05034250 | Iron Status in Female Infertility and Recurrent Miscarriage | ||
| NCT02846896 | The Health Burden of Primary Biliary Cirrhosis (PBC) in Switzerland | ||
| NCT00868439 | Evaluation of Patiromer in Heart Failure Patients | ||
| NCT01324752 | A Drug-Drug Interaction Study of Losartan and PA21 | ||
| NCT05861492 | FDDA Utilization Study (FDDAU) | ||
| NCT00706667 | Intravenous Ferric Carboxymaltose (Ferinject®) With or Without Erythropoietin in Patients Undergoing Orthopaedic Surgery | ||
| NCT03888066 | Patiromer for the Management of Hyperkalemia in Subjects Receiving RAASi Medications for the Treatment of Heart Failure (DIAMOND) | ||
| NCT01438359 | A Drug-Drug Interaction Study of Furosemide and PA21 | ||
| NCT05524467 | Cross-sectional Study to Assess Prevalence and Burden of CKD-associated Pruritus in Haemodialysis Patients | ||
| NCT05514951 | Study of the Prevalence of Iron Deficiency in Elderly Patient in Hospital Environment | ||
| NCT03769441 | Effect of Ferric Carboxymaltose on Exercise Capacity After Kidney Transplantation | ||
| NCT04806048 | Feasibility of Implementation of Recommended Standards in Patients With Heart Failure | ||
| NCT03957187 | Prevalence and Clinical Associates of Iron Deficiency in Patients With Atrial Fibrillation | ||
| NCT06256991 | Potassium Correction for RAAS Optimization in Chronic Kidney Disease |
